Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06820034 · ClinicalTrials.gov registry record · Phase 2
Empowering Cessation ACS South Region
A Phase 2 study, sponsored by University of Oklahoma.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 400
- Enrollment target
NCT06820034 is a Phase 2 study that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 400 participants.
The verdict
NCT06820034, a Phase 2 study, is actively recruiting participants, sponsored by University of Oklahoma.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 400 participants
- Enrollment target
Study Summary
Sexual and/or gender minority (SGM) people face a disproportionate burden of cancer risk, and tobacco use is a key modifiable risk factor. SGM tobacco-related disparities are especially pronounced in places with high levels of stigma against SGM people. This community-engaged and remotely-delivered Research Scholar Grant project will evaluate an empowerment-based smoking cessation intervention tailored for SGM people in high-stigma places. In partnership with Freedom Oklahoma (OK) and a Community Advisory Board from Arkansas (AR) and Texas (TX) this projects aims to: (1) Adapt SGM-serving volunteer activities from the Oklahoma intervention pilot study for delivery in nearby states; (2) Test intervention efficacy among SGM adults in OK, AR, and TX; (3) Identify treatment mechanisms.
Interventions
- OTHER Empowering Cessation for the ACS South
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-08-14 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06820034
The ClinicalTrials.gov registry entry for NCT06820034 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Empowering Cessation for the ACS South is the first listed.
NCT06820034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06820034 about?
NCT06820034 is a clinical study titled "Empowering Cessation ACS South Region". Sexual and/or gender minority (SGM) people face a disproportionate burden of cancer risk, and tobacco use is a key modifiable risk factor. SGM tobacco-related disparities are especially pronounced in places with high levels of stigma against SGM people. This community-engaged and remotely-delivered ...
What is the current status of trial NCT06820034?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 400 participants. The study started on 2025-08-14. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT06820034?
The interventions under investigation include: Empowering Cessation for the ACS South (OTHER).
Who is sponsoring clinical trial NCT06820034?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.